SCHEMBL28061383

SCHEMBL28061383

[O]C(=O)Cc1cc(F)ccc1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.47
CES1 P23141 2/20 0.47
MAPK8 P45983 1/20 0.47
RIPK1 Q13546 1/20 0.45
PSEN1 P49768 1/20 0.42
PSEN2 P49810 1/20 0.42
APH1B Q8WW43 1/20 0.42
NCSTN Q92542 1/20 0.42
APH1A Q96BI3 1/20 0.42
PSENEN Q9NZ42 1/20 0.42
SIGMAR1 Q99720 1/20 0.42
CA3 P07451 1/20 0.41
CA6 P23280 1/20 0.41
CA5A P35218 1/20 0.41
CA9 Q16790 1/20 0.41
CA14 Q9ULX7 1/20 0.41
CA5B Q9Y2D0 1/20 0.41
MMP2 P08253 2/20 0.41
MMP12 P39900 2/20 0.41
MMP1 P03956 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6858298 0.85 CES2 (0.48) CES2CES1MAPK8RIPK1PSEN1
SCHEMBL503667 0.83 TSHR (0.53) CES2CES1MAPK8RIPK1PSEN1
SCHEMBL29471363 0.83 TSHR (0.53) CES2CES1MAPK8RIPK1PSEN1
SCHEMBL1115079 0.82 MAPK8 (0.52) CES2CES1MAPK8RIPK1PSEN1
SCHEMBL892996 0.82 MAPK8 (0.46) CES2CES1MAPK8RIPK1PSEN1
SCHEMBL14263434 0.82 RIPK1 (0.47) CES2CES1MAPK8RIPK1PSEN1
SCHEMBL28038980 0.82 CES2 (0.45) CES2CES1MAPK8RIPK1PSEN1
SCHEMBL1478187 0.80 FFAR1 (0.51) CES2CES1
SCHEMBL13061970 0.79 RIPK1 (0.49) CES2CES1MAPK8RIPK1PSEN1
SCHEMBL1477462 0.79 PSEN1 (0.42) CES2CES1MAPK8RIPK1PSEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102803252-B Be used for the treatment of indole amides derivative and the related compound thereof of neurodegenerative disorders K.U. LEUVEN RESEARCH & DEVELOPMENT (BE) 2016-05-25 CN disclosed